topic0
Chronic hepatitis C [dsyn] 0.00291281321421
Higher [qlco] 0.00280866912445
Based [ftcn] 0.00275169321163
Survival [acty] 0.00509088687157
Group [idcn] 0.00461822887696
resection [topp] 0.00246304228132
Relationship [qlco] 0.00304659680272
Including [ftcn] 0.00300662322159
HEPATITIS C VIRUS [virs] 0.00405056481246
Groups [idcn] 0.00266574344502
Hepatic [blor] 0.00658032078203
Hepatectomy [topp] 0.00280239913373
Performed [ftcn] 0.00249649886967
LIVER DISEASE [dsyn] 0.0039690035863
Study [mnob] 0.0109566669494
Mortality [qnco] 0.00346663556908
LIVER CIRRHOSIS [dsyn] 0.00340354781883
Methods [inpr] 0.00474223570169
Compared [acty] 0.00309353846712
Cases [ftcn] 0.00393968761545
Negative [qlco] 0.00247967062888
YEARS [tmco] 0.00756805888968
Human [humn] 0.00501251924845
Women [popg] 0.00358929082771
Liver Transplantation [topp] 0.00366465345034
YEAR [tmco] 0.00278986559283
LIVER [bpoc] 0.00989573134311
Conclusions [idcn] 0.00387728355693
Related [qlco] 0.00284495399259
control [qlco] 0.00606069911406
Postoperative [tmco] 0.00270609110558
Greater [qnco] 0.00267399447917
treatment [ftcn] 0.00425051240815
CIRRHOSIS [dsyn] 0.0135999804018
Complications [patf] 0.00292094569268
FIBROSIS [patf] 0.00372663445065
Cirrhotic [qlco] 0.0028250551424
Liver Cancer [neop] 0.00297486850235
Risk Factors [qnco] 0.00606876782574
Increased [qnco] 0.00493597548045
topic1
Tumour NOS [neop] 0.00268647723637
HCV [virs] 0.00469598470545
Present [qnco] 0.00281759064932
Groups [idcn] 0.00306091398045
Group [idcn] 0.00466899605384
resection [topp] 0.00480695794298
Known [qlco] 0.00235278613226
HEPATITIS C VIRUS [virs] 0.00326204161514
Complication [patf] 0.00338250761458
Hepatic [blor] 0.00269947915844
variables [qlco] 0.00238015449049
Suggest [idcn] 0.00292212416549
Study [mnob] 0.00701801875594
control [qlco] 0.00357057775975
DIAGNOSIS [fndg] 0.0025186336645
Chronic hepatitis C [dsyn] 0.00295033440319
Methods [inpr] 0.00291479706121
Risk Factors [qnco] 0.0072539250557
Cases [ftcn] 0.017303473444
YEARS [tmco] 0.00335050009677
Greater [qnco] 0.00264764885341
MALIGNANCY [neop] 0.00237585853205
DEATH [orgf] 0.00281204909456
LOWER [spco] 0.00240670543362
YEAR [tmco] 0.00359730334057
LIVER [bpoc] 0.00638772075879
Conclusions [idcn] 0.00285062126142
Rupture [phpr] 0.00232530107191
Hepatitis C [dsyn] 0.0058350501365
Genotype [orga] 0.00233683507991
TIME [tmco] 0.00239821344746
Focal Nodular Hyperplasia [dsyn] 0.00299557018338
Progression [patf] 0.00232861348093
Odds Ratio [qnco] 0.00694460935296
treatment [ftcn] 0.0041881092682
CIRRHOSIS [dsyn] 0.00332759588839
Compared [acty] 0.00404812084387
Genes [gngm] 0.00353957414704
CANCER [neop] 0.00280540243745
Increased [qnco] 0.00401913628317
topic2
Tumour NOS [neop] 0.00332489351753
HCV [virs] 0.00263633962781
Morbidity [qnco] 0.00287254755435
Radiofrequency Ablation [topp] 0.00395851434111
Higher [qlco] 0.00280284507182
Groups [idcn] 0.0029326926439
Survival [acty] 0.0070097051906
Group [idcn] 0.0134007603023
resection [topp] 0.00819526838943
Including [ftcn] 0.00267438294891
HEPATITIS C VIRUS [virs] 0.00951210522196
Important [qlco] 0.00263146493525
lesions [fndg] 0.00268021844407
Hepatic [blor] 0.00633385377817
Liver Cancer [neop] 0.00290433735204
Hepatocellular Carcinomas [neop] 0.00265492185617
HEPATITIS B VIRUS [virs] 0.00415603720434
LOCAL [spco] 0.00368647139293
Study [mnob] 0.00765774071153
Mortality [qnco] 0.00862297708518
Methods [inpr] 0.0037880300655
Men [popg] 0.0031731496894
Risk Factors [qnco] 0.00627538581955
Hepatitis C virus infection [dsyn] 0.0041818288808
Cases [ftcn] 0.00576144341516
Treated [ftcn] 0.00299947154148
YEARS [tmco] 0.00601808940384
Women [popg] 0.00266731061114
YEAR [tmco] 0.00378182837849
LIVER [bpoc] 0.006966843398
Long Term [tmco] 0.00396776000718
Related [qlco] 0.00418571156789
Genotype [orga] 0.00274012245619
treatment [ftcn] 0.00277806302199
CIRRHOSIS [dsyn] 0.0106888792616
Cirrhotic [qlco] 0.00495455068021
Levels [qlco] 0.00333991225271
Compared [acty] 0.00379990568341
Tumors [neop] 0.00266656111137
Increased [qnco] 0.00325493945529
topic3
Obtained [ftcn] 0.00216381418967
Tumour NOS [neop] 0.00417272769917
Microvessel Density [qlco] 0.00243562163094
Incidence Rate [qnco] 0.0022999352794
resection [topp] 0.00625316539962
CHOLANGITIS, PRIMARY SCLEROSING [dsyn] 0.00249615742089
Including [ftcn] 0.00325784834448
HEPATITIS C VIRUS [virs] 0.00284168181027
SMALL [qnco] 0.0020515655671
lesions [fndg] 0.00309924833317
Therapeutic [topp] 0.00216952819634
Hepatic [blor] 0.00487394929271
Hepatocellular Carcinomas [neop] 0.00297791453944
DIAGNOSIS [fndg] 0.00283089083328
HCCS [gngm] 0.00225628998308
Study [mnob] 0.00745523230469
included [ftcn] 0.0020231243306
Suggest [idcn] 0.00418148263921
Conclusions [idcn] 0.00199992532229
Methods [inpr] 0.00452549219374
CANCER [neop] 0.00309314511907
Hepatitis C virus infection [dsyn] 0.00201465783927
betel quid [food] 0.00242391874575
Cases [ftcn] 0.00889571820891
Equal [qlco] 0.00207026627848
Hepatitis B, Chronic [dsyn] 0.00209558711936
YEARS [tmco] 0.00493476443148
Cholangiocarcinoma [neop] 0.0081656051285
DEATH [orgf] 0.00217760808308
YEAR [tmco] 0.0038520825638
LIVER [bpoc] 0.00788999080788
strategies [menp] 0.0019813409745
treatment [ftcn] 0.00812896416519
CIRRHOSIS [dsyn] 0.00735852308433
afb [bact] 0.00229161697114
Risk Factors [qnco] 0.00538629968847
Pathology [bmod] 0.00222592706208
Tumors [neop] 0.00295740886211
pathogenesis [ftcn] 0.00226042753107
NEW [qlco] 0.00237760236614
topic4
Satellite [spco] 0.00327962885724
Tumour NOS [neop] 0.00366297014653
Treated [ftcn] 0.00420330326583
Groups [idcn] 0.00256219032632
Survival [acty] 0.00367077677313
Group [idcn] 0.00479582413384
resection [topp] 0.00772721159862
HEPATITIS C VIRUS [virs] 0.00686063363355
lesions [fndg] 0.00630172673407
Hepatic [blor] 0.0033363382524
Subject [grup] 0.00253869165002
Liver Cancer [neop] 0.00257346990919
Hepatectomy [topp] 0.00339944089871
Hepatocellular Carcinomas [neop] 0.0034766927598
LOCAL [spco] 0.00310062777124
Study [mnob] 0.00566894748972
LIVER CIRRHOSIS [dsyn] 0.00435965250082
Methods [inpr] 0.00558391717302
Risk Factors [qnco] 0.0073596158876
Hepatitis C virus infection [dsyn] 0.00321918489327
Cases [ftcn] 0.00289073193284
Negative [qlco] 0.00247552691532
Equal [qlco] 0.00269949497426
Radiofrequency Ablation [topp] 0.00272226642667
YEARS [tmco] 0.0156220384758
Human [humn] 0.00502787306489
therapy [ftcn] 0.00270230832328
YEAR [tmco] 0.00327781234803
LIVER [bpoc] 0.00553252864255
Conclusions [idcn] 0.00330571510426
Related [qlco] 0.00401151515652
treatment [ftcn] 0.00808131309489
CIRRHOSIS [dsyn] 0.00424423077141
Single [popg] 0.0028277559696
Cirrhotic [qlco] 0.00371447554615
Reserve [acty] 0.00272222721656
Compared [acty] 0.00349531013286
Performed [ftcn] 0.0025393325482
Tumors [neop] 0.00682497171052
Increased [qnco] 0.00384607222874
topic5
Tumour NOS [neop] 0.00769238147837
Higher [qlco] 0.00298753122304
Survival [acty] 0.00632560248832
Group [idcn] 0.00308693634629
resection [topp] 0.00730919431396
CHOLANGITIS, PRIMARY SCLEROSING [dsyn] 0.00292633626962
HEPATITIS C VIRUS [virs] 0.00463014656221
lesions [fndg] 0.00277631765263
Intrahepatic [spco] 0.00446910278308
Hepatic [blor] 0.00429835817604
HEPATITIS B VIRUS [virs] 0.00832076773466
SERUM [bdsu] 0.00238957187404
DIAGNOSIS [fndg] 0.00407844486839
Study [mnob] 0.0106525159721
Mortality [qnco] 0.00323509926698
Independent [idcn] 0.00269739832654
Conclusions [idcn] 0.00314621268342
Low [qlco] 0.00328327352752
Methods [inpr] 0.00375664080266
Risk Factors [qnco] 0.010140337288
Hepatitis C virus infection [dsyn] 0.0033652381168
Cases [ftcn] 0.00411831127777
chemoembolisation [topp] 0.00263865863332
YEARS [tmco] 0.00564883006147
included [ftcn] 0.0024004077963
Greater [qnco] 0.00255982056686
Cholangiocarcinoma [neop] 0.0080910629224
YEAR [tmco] 0.00465790778864
LIVER [bpoc] 0.00521795818826
Related [qlco] 0.00688943882245
Postoperative [tmco] 0.00277353574299
Progression [patf] 0.00247819229714
treatment [ftcn] 0.00325616948297
CIRRHOSIS [dsyn] 0.00451706023258
FIBROSIS [patf] 0.0031569886688
Levels [qlco] 0.00420939083854
Compared [acty] 0.00405465133485
Tumors [neop] 0.00273504586955
Median [spco] 0.00277023712126
HCC [neop] 0.00579590111221
topic6
Tumour NOS [neop] 0.0050400841599
Higher [qlco] 0.00403197813312
Survival [acty] 0.00849172179013
Group [idcn] 0.0047242182931
resection [topp] 0.00467666945862
CI [geoa] 0.00400906632029
HEPATITIS C VIRUS [virs] 0.00578925909744
Biliary Cirrhosis, Primary [dsyn] 0.00677822232017
Hepatic [blor] 0.00267711445452
Hepatocellular Carcinomas [neop] 0.00426636467057
HEPATITIS B VIRUS [virs] 0.00323164884338
TYPE [qlco] 0.00586038278996
Suggest [idcn] 0.00264546120711
Study [mnob] 0.00705786871874
control [qlco] 0.00541142126741
Conclusions [idcn] 0.00426007936786
Low [qlco] 0.00285815150378
Methods [inpr] 0.00569704177523
Infected [fndg] 0.00285864622756
Risk Factors [qnco] 0.00563034628073
Cases [ftcn] 0.00543400328455
Negative [qlco] 0.00334568227774
chemoembolisation [topp] 0.0041073723297
YEARS [tmco] 0.00502023551254
Transcatheter [spco] 0.0036614959485
Mortality [qnco] 0.00279286133301
Cholangiocarcinoma [neop] 0.00264069913952
Liver Transplantation [topp] 0.00298536515363
LOWER [spco] 0.00271253688063
YEAR [tmco] 0.00546858711785
LIVER [bpoc] 0.00606985464823
Related [qlco] 0.00278518378032
treatment [ftcn] 0.00315332293056
CIRRHOSIS [dsyn] 0.0046396532362
Increased [qnco] 0.00274801304104
Compared [acty] 0.00583763906944
Performed [ftcn] 0.00359690486876
Examined [fndg] 0.00303155009971
Single [popg] 0.00361216848578
HCC [neop] 0.00300444786272
topic7
Performed [ftcn] 0.00303488575582
Compared [acty] 0.00282239997294
Survival [acty] 0.00230582002072
resection [topp] 0.00381891990941
Phase [tmco] 0.00281147863709
Including [ftcn] 0.00263004583003
HEPATITIS C VIRUS [virs] 0.00312505185651
Correlation [qlco] 0.0022860266592
Nodules [acab] 0.00267455744233
Hepatic [blor] 0.0035078705485
Hepatectomy [topp] 0.00250633719047
Hepatocellular Carcinomas [neop] 0.003388337314
Observed [ftcn] 0.00246635649689
DIAGNOSIS [fndg] 0.00324261505083
Study [mnob] 0.00480346212776
Mortality [qnco] 0.00356185960467
Suggest [idcn] 0.00249006998499
Methods [inpr] 0.00442192936189
Men [popg] 0.0026001103247
CANCER [neop] 0.00352840246889
Cases [ftcn] 0.00641173492503
YEARS [tmco] 0.00590749363943
Human [humn] 0.00389393102329
CHINA [geoa] 0.00235855637358
Cholangiocarcinoma [neop] 0.00219098597463
UNITED STATES [geoa] 0.00224707461429
LIVER [bpoc] 0.00800614321887
Identified [qlco] 0.00358475739422
Odds Ratio [qnco] 0.00292383203408
MR [gngm] 0.00344853147075
CIRRHOSIS [dsyn] 0.00446020832445
SCORE [qnco] 0.00251361558209
Cirrhotic [qlco] 0.00315517703366
Reporting [hlca] 0.00235671768344
Risk Factors [qnco] 0.00595835720145
weighted [orga] 0.0021831150886
Tumors [neop] 0.00272090562503
Increased [qnco] 0.00443803093254
HCC [neop] 0.00328938171514
Interferon Therapy [topp] 0.00260179063949
topic8
Tumour NOS [neop] 0.00447579571455
HCV [virs] 0.00310423426086
Disease-Free Survival [qnco] 0.00275745726621
Radiofrequency Ablation [topp] 0.00301973256938
Survival [acty] 0.00329211638813
Relationship [qlco] 0.00262719104955
HEPATITIS C VIRUS [virs] 0.00393712311345
tumor recurrence [neop] 0.00341367000324
Subject [grup] 0.00409642092477
Hepatectomy [topp] 0.00273500378999
Performed [ftcn] 0.00337910660877
HEPATITIS B VIRUS [virs] 0.00421697319445
Observed [ftcn] 0.00446072013595
Suggest [idcn] 0.0033065566576
Study [mnob] 0.00636158141961
control [qlco] 0.00383067973329
Response [orga] 0.00481101292071
Conclusions [idcn] 0.00340765677301
Methods [inpr] 0.00448689041097
Compared [acty] 0.00381732815227
Hepatitis C virus infection [dsyn] 0.00483554145208
Cases [ftcn] 0.00469585002635
liver resection [topp] 0.00340728661133
YEARS [tmco] 0.00428006563237
included [ftcn] 0.00296725524362
therapy [ftcn] 0.00277882724872
Peritoneal [bpoc] 0.00355227450172
YEAR [tmco] 0.00377572957287
LIVER [bpoc] 0.00630671055651
Related [qlco] 0.00503092827384
DIAMETER [qnco] 0.00320832058082
Identified [qlco] 0.00487352746195
Region [geoa] 0.00368124927014
CIRRHOSIS [dsyn] 0.00442512365953
Single [popg] 0.00267679847952
Cirrhotic [qlco] 0.00306777489912
Levels [qlco] 0.00304945285144
afb [bact] 0.00382829273646
Risk Factors [qnco] 0.00896069616774
Increased [qnco] 0.00311974610985
topic9
Tumour NOS [neop] 0.00473801951331
Significantly high [qnco] 0.00229370761137
HCV [virs] 0.00641881399198
Suggest [idcn] 0.00331198011015
Groups [idcn] 0.00362039608921
Survival [acty] 0.00328826894466
Group [idcn] 0.00489489035209
resection [topp] 0.00981784203558
Including [ftcn] 0.00342378114763
HEPATITIS C VIRUS [virs] 0.00945503735066
Hepatic [blor] 0.00746203250532
Subject [grup] 0.00268301607682
HEPATITIS B VIRUS [virs] 0.00283849771141
LIVER DISEASE [dsyn] 0.00542592085988
CHRONIC [tmco] 0.00285779841197
Study [mnob] 0.00697619873361
control [qlco] 0.00309612579209
Independent [idcn] 0.0033741816651
Conclusions [idcn] 0.0042497268526
Methods [inpr] 0.00406509681955
Infected [fndg] 0.00406565943907
Risk Factors [qnco] 0.00945715963105
Cases [ftcn] 0.00407444843735
Equal [qlco] 0.00258392202406
YEARS [tmco] 0.00601833180846
percutaneous ethanol injection [topp] 0.00241568842123
therapy [ftcn] 0.00264365526884
Liver Transplantation [topp] 0.00427884502995
Response [orga] 0.00285969164346
LIVER [bpoc] 0.00372265905203
LIVER CIRRHOSIS [dsyn] 0.00255016130605
Related [qlco] 0.00388434290642
Genotype [orga] 0.00295177170993
Postoperative [tmco] 0.00232132993955
Identified [qlco] 0.00246873202925
treatment [ftcn] 0.0034162327104
CIRRHOSIS [dsyn] 0.00445601460492
Compared [acty] 0.00380941054138
P53 [gngm] 0.00287514509977
Increased [qnco] 0.00261293764988
